Oncolytics Biotech Inc.(ONCY)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | Parsons James T. Director | Purchase | +10,000 | +31.40%41,849 | $1.03 | $10,300 | View SEC filing | |
| 2026-03-13 | Kelly Jared Chief Executive Officer | Purchase | +5,050 | +4.63%114,050 | $0.96 | $4,848 | View SEC filing | |
| 2026-02-13 | Seizinger Bernd R. Director | Purchase | +100,000 | +21.41%566,991 | $0.83 | $83,454 | View SEC filing | |
| 2026-02-13 | Pisano Wayne Director | Purchase | +30,000 | +6.49%492,414 | $0.84 | $25,338 | View SEC filing | |
| 2026-02-13 | Look Kirk Chief Financial Officer | Purchase | +12,000 | +4.36%287,515 | $0.84 | $10,104 | View SEC filing | |
| 2026-02-13 | Kelly Jared Chief Executive Officer | Purchase | +35,100 | +47.50%109,000 | $0.84 | $29,521 | View SEC filing | |
| 2026-02-13 | Heineman Thomas Charles Chief Medical Officer | Purchase | +12,132 | +4.48%282,818 | $0.83 | $10,033 | View SEC filing | |
| 2026-02-13 | Hagerman Allison VP, Product Development | Purchase | +10,000 | +9.52%115,059 | $0.83 | $8,298 | View SEC filing | |
| 2026-02-13 | Brown Deborah Margaret Director | Purchase | +25,000 | +29.46%109,851 | $0.85 | $21,240 | View SEC filing | |
| 2026-02-13 | Aromando Andrew Chief Business Officer | Purchase | +29,600 | +116.08%55,100 | $0.86 | $25,418 | View SEC filing | |
| 2026-02-13 | Andrews Patricia S Director | Purchase | +35,400 | +82.85%78,128 | $0.86 | $30,292 | View SEC filing | |
| 2026-01-20 | Seizinger Bernd R. Director | Purchase | +100,000 | +27.25%466,991 | $1.04 | $103,770 | View SEC filing |
1-12 of 12